MICROPOS MEDICAL AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.64 SEK | -2.96% |
|
-.--% | -3.53% |
| Apr. 30 | Micropos Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Jan. 31 | Micropos Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 91.4 | 71.31 | 83.2 | 338.3 | 423 | 365.9 |
| Enterprise Value (EV) 1 | 81.06 | 52 | 74.56 | 331.5 | 404.5 | 363 |
| P/E ratio | -6.38 x | -4.67 x | -7 x | -29.8 x | -28.3 x | -19.5 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 45.7 x | 58.1 x | 24.1 x | 45.5 x | 126 x | 336 x |
| EV / Revenue | 40.6 x | 42.4 x | 21.6 x | 44.6 x | 120 x | 333 x |
| EV / EBITDA | -5.77 x | -3.38 x | -6.41 x | -28.7 x | -28.1 x | -19.6 x |
| EV / FCF | -10.4 x | -7.68 x | -5.42 x | -32.3 x | -48 x | -10.7 x |
| FCF Yield | -9.6% | -13% | -18.5% | -3.1% | -2.09% | -9.36% |
| Price to Book | 8.1 x | 4.12 x | 6.38 x | 24.5 x | 17.5 x | 11.6 x |
| Nbr of stocks (in thousands) | 59,738 | 84,896 | 84,896 | 113,522 | 124,401 | 124,895 |
| Reference price 2 | 1.530 | 0.8400 | 0.9800 | 2.980 | 3.400 | 2.930 |
| Announcement Date | 4/30/18 | 4/17/19 | 4/30/20 | 4/27/21 | 7/7/22 | 5/3/23 |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.999 | 1.227 | 3.458 | 7.433 | 3.368 | 1.09 |
| EBITDA 1 | -14.05 | -15.37 | -11.64 | -11.54 | -14.38 | -18.49 |
| EBIT 1 | -14.25 | -15.52 | -11.76 | -11.6 | -14.41 | -18.53 |
| Operating Margin | -712.75% | -1,264.21% | -340.06% | -156.02% | -427.89% | -1,699.58% |
| Earnings before Tax (EBT) 1 | -14.27 | -15.53 | -11.75 | -11.68 | -14.42 | -18.6 |
| Net income 1 | -14.27 | -15.53 | -11.75 | -11.68 | -14.42 | -18.6 |
| Net margin | -713.66% | -1,265.74% | -339.93% | -157.08% | -428.23% | -1,705.79% |
| EPS 2 | -0.2400 | -0.1800 | -0.1400 | -0.1000 | -0.1200 | -0.1500 |
| Free Cash Flow 1 | -7.779 | -6.771 | -13.76 | -10.26 | -8.434 | -33.96 |
| FCF margin | -389.17% | -551.7% | -397.98% | -138.09% | -250.44% | -3,114.83% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/30/18 | 4/17/19 | 4/30/20 | 4/27/21 | 7/7/22 | 5/3/23 |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 10.3 | 19.3 | 8.64 | 6.77 | 18.5 | 2.98 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -7.78 | -6.77 | -13.8 | -10.3 | -8.43 | -34 |
| ROE (net income / shareholders' equity) | -77.5% | -109% | -77.4% | -87% | -77.1% | -66.8% |
| ROA (Net income/ Total Assets) | -38.3% | -50% | -36% | -38.3% | -36.2% | -33.7% |
| Assets 1 | 37.22 | 31.05 | 32.65 | 30.49 | 39.88 | 55.18 |
| Book Value Per Share 2 | 0.1900 | 0.2000 | 0.1500 | 0.1200 | 0.1900 | 0.2500 |
| Cash Flow per Share 2 | 0.1800 | 0.2300 | 0.1100 | 0.0600 | 0.1500 | 0.0300 |
| Capex | - | - | - | 0.13 | 0.05 | 0.03 |
| Capex / Sales | - | - | - | 1.69% | 1.4% | 2.43% |
| Announcement Date | 4/30/18 | 4/17/19 | 4/30/20 | 4/27/21 | 7/7/22 | 5/3/23 |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -3.53% | 23.92M | |
| +7.40% | 217B | |
| +13.63% | 194B | |
| +20.05% | 143B | |
| +31.15% | 111B | |
| +3.08% | 64.3B | |
| +15.02% | 52.94B | |
| +2.72% | 49.53B | |
| -5.80% | 38.31B | |
| -0.39% | 35.22B |
- Stock Market
- Equities
- MPOS Stock
- Financials Micropos Medical AB
